BR1100704KB1 - vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli. - Google Patents

vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.

Info

Publication number
BR1100704KB1
BR1100704KB1 BRPP1100704-4KB1A BR1100704A BR1100704KB1 BR 1100704K B1 BR1100704K B1 BR 1100704KB1 BR 1100704 A BR1100704 A BR 1100704A BR 1100704K B1 BR1100704K B1 BR 1100704KB1
Authority
BR
Brazil
Prior art keywords
polypeptide
producing
dna
strain
methods
Prior art date
Application number
BRPP1100704-4KB1A
Other languages
English (en)
Inventor
Katsutoshi Sasaki
Kazumi Miura
Nobuo Hanai
Tatsunari Nishi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13390376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100704K(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of BR1100704KB1 publication Critical patent/BR1100704KB1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPP1100704-4KB1A 1993-03-29 1997-05-08 vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli. BR1100704KB1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6901693 1993-03-29

Publications (1)

Publication Number Publication Date
BR1100704KB1 true BR1100704KB1 (pt) 2011-10-18

Family

ID=13390376

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPP1100704-4KB1A BR1100704KB1 (pt) 1993-03-29 1997-05-08 vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.

Country Status (7)

Country Link
US (2) US7094530B1 (pt)
EP (1) EP0643132B1 (pt)
JP (1) JP3756946B2 (pt)
BR (1) BR1100704KB1 (pt)
DE (1) DE69434749T2 (pt)
SG (1) SG49117A1 (pt)
WO (1) WO1994023021A1 (pt)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595900A (en) * 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
JP3756946B2 (ja) 1993-03-29 2006-03-22 協和醗酵工業株式会社 α１，３−フコシルトランスフェラーゼ
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US5770420A (en) * 1995-09-08 1998-06-23 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1997032889A1 (en) * 1996-03-08 1997-09-12 The Regents Of The University Of Michigan MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID
WO1999048926A1 (fr) * 1998-03-24 1999-09-30 Kyowa Hakko Kogyo Co., Ltd. ANTICORPS DIRIGE CONTRE LA α1,3-FUCOSYLTRANSFERASE (Fuc-TVII) HUMAINE
AT408446B (de) 1999-02-18 2001-11-26 Altmann Friedrich Dr Fucosyltransferase-gen
CA2704600C (en) * 1999-04-09 2016-10-25 Kyowa Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
JP2004528001A (ja) * 2000-05-12 2004-09-16 ネオーズ テクノロジーズ， インコーポレイテッド インビトロにおけるフコシル化組換えグリコペプチド
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
DE60336555D1 (de) 2002-06-21 2011-05-12 Novo Nordisk Healthcare Ag Pegylierte glykoformen von faktor vii
WO2004058960A1 (ja) 2002-12-26 2004-07-15 Kyowa Hakko Kogyo Co., Ltd. ジペプチドの製造法
NZ542094A (en) 2003-03-14 2008-12-24 Neose Technologies Inc Branched polymer conjugates comprising a peptide and water-soluble polymer chains
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
DE602005017707D1 (de) 2004-06-25 2009-12-31 Kyowa Hakko Bio Co Ltd Verfahren zur Herstellung von Dipeptiden oder Dipeptidderivaten.
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2975135A1 (en) 2005-05-25 2016-01-20 Novo Nordisk A/S Glycopegylated factor IX
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
WO2007066698A1 (ja) 2005-12-06 2007-06-14 Kyowa Hakko Kogyo Co., Ltd. 抗ｐｅｒｐ遺伝子組換え抗体
US8067211B2 (en) 2005-12-27 2011-11-29 Kyowa Hakko Bio Co., Ltd. Method for production of L-glutamine
WO2007142277A1 (ja) 2006-06-06 2007-12-13 Kyowa Hakko Kirin Co., Ltd. ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
EP2049144B8 (en) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation of peptides via o-linked glycosylation sequences
WO2008038613A1 (fr) 2006-09-25 2008-04-03 Kyowa Hakko Bio Co., Ltd. Procédé de production de dipeptide
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
US20110236374A1 (en) 2007-01-24 2011-09-29 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
AU2008208288B2 (en) 2007-01-24 2014-04-03 Kyowa Kirin Co., Ltd. Genetically recombinant antibody composition having enhanced effector activity
EP2123751A4 (en) 2007-01-25 2010-06-02 Kyowa Hakko Kirin Co Ltd NEW PEPTIDE
AU2008227024A1 (en) * 2007-03-07 2008-09-18 Glycofi, Inc. Production of glycoproteins with modified fucosylation
JPWO2008114733A1 (ja) 2007-03-16 2010-07-01 協和発酵キリン株式会社 抗Ｃｌａｕｄｉｎ−４抗体
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
JP5532401B2 (ja) 2007-12-05 2014-06-25 協和発酵キリン株式会社 ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
CA2729567C (en) 2008-06-30 2018-04-24 Kyowa Hakko Kirin Co., Ltd. Anti-cd27 antibody
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
US8268592B2 (en) 2008-07-17 2012-09-18 Kyowa Hakko Kirin Co., Ltd Anti-system ASC amino acid transporter 2 (ASCT2) antibody
US8304249B2 (en) 2008-10-09 2012-11-06 Kyowa Medex Co., Ltd. Fructosyl peptide oxidase
PT2374883T (pt) 2008-12-26 2016-10-20 Kyowa Hakko Kirin Co Ltd Anticorpo anti-cd4
ES2829423T3 (es) 2009-04-20 2021-05-31 Kyowa Kirin Co Ltd Anticuerpo anti-CD40 que contiene IgG2 que presenta tres mutaciones de aminoácido introducidas en el mismo
ES2602971T3 (es) 2010-03-02 2017-02-23 Kyowa Hakko Kirin Co., Ltd. Composición de anticuerpo modificado
AU2011262758B8 (en) 2010-06-11 2014-09-04 Kyowa Kirin Co., Ltd. Anti-tim-3 antibody
US20130130317A1 (en) 2010-08-02 2013-05-23 Kyowa Hakko Kirin Co., Ltd Method for producing substance
WO2012091023A1 (ja) 2010-12-27 2012-07-05 協和発酵キリン株式会社 培地およびキレート剤を含む水溶液の調製方法
JPWO2012176779A1 (ja) 2011-06-20 2015-02-23 協和発酵キリン株式会社 抗ｅｒｂＢ３抗体
EP2852610B1 (en) 2012-05-23 2018-07-11 Glykos Finland Oy Production of fucosylated glycoproteins
CN104411720B (zh) 2012-07-02 2018-05-11 协和发酵麒麟株式会社 以抗bmp9抗体作为有效成分的、对肾性贫血、癌性贫血等贫血的治疗剂
US9207238B2 (en) 2012-12-07 2015-12-08 Kyowa Hakko Kirin Co., Ltd. Anti-FOLR1 antibody
WO2015005258A1 (ja) 2013-07-09 2015-01-15 協和メデックス株式会社 糖化ヘキサペプチドオキシダーゼとその利用
SG11201700446XA (en) 2014-07-21 2017-02-27 Glykos Finland Oy Production of glycoproteins with mammalian-like n-glycans in filamentous fungi
AU2015315110B2 (en) * 2014-09-09 2021-04-08 Glycosyn LLC Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides
US11912775B2 (en) 2017-07-18 2024-02-27 Kyowa Kirin Co., Ltd. Anti-human CCR1 monoclonal antibody
WO2019022163A1 (ja) 2017-07-26 2019-01-31 Ｓｐｉｂｅｒ株式会社 改変フィブロイン
CA3081854A1 (en) 2017-11-08 2019-05-16 Kyowa Kirin Co., Ltd. Bispecific antibody which binds to cd40 and epcam
WO2019117208A1 (ja) 2017-12-12 2019-06-20 協和発酵キリン株式会社 抗ｂｍｐ１０抗体及び該抗体を有効成分とする、高血圧および高血圧性疾患に対する治療剤
JP7397444B2 (ja) 2018-06-26 2023-12-13 協和キリン株式会社 コンドロイチン硫酸プロテオグリカン－５に結合する抗体
TWI857959B (zh) 2018-06-26 2024-10-11 日商協和麒麟股份有限公司 與細胞黏著分子3 結合之抗體
EP3875595A4 (en) 2018-11-02 2022-07-13 Kyowa Kirin Co., Ltd. Liquid medium preparation method
WO2020138487A1 (ja) 2018-12-28 2020-07-02 協和キリン株式会社 ＴｆＲに結合するバイスペシフィック抗体
US12319718B2 (en) 2019-01-09 2025-06-03 Spiber Inc. Modified fibroin
WO2020230901A1 (ja) 2019-05-15 2020-11-19 協和キリン株式会社 Ｃｄ４０とｇｐｃ３に結合するバイスペシフィック抗体
WO2020230899A1 (ja) 2019-05-15 2020-11-19 協和キリン株式会社 Ｃｄ４０とｆａｐに結合するバイスペシフィック抗体
TWI888487B (zh) 2020-02-14 2025-07-01 日商協和麒麟股份有限公司 與ｃｄ３結合之雙特異性抗體
JPWO2021187502A1 (pt) 2020-03-16 2021-09-23
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
CA3229748A1 (en) 2021-08-26 2023-03-02 Akifumi Kato Bispecific antibody that binds to cd116 and cd131
JPWO2023090372A1 (pt) 2021-11-16 2023-05-25
US20250382371A1 (en) 2022-02-09 2025-12-18 National Institutes Of Biomedical Innovation, Health And Nutrition Antibody or fragment thereof that binds to fcrl1
KR20250049545A (ko) 2022-08-10 2025-04-11 쿄와 기린 가부시키가이샤 항fgf23 항체 또는 해당 항체 단편
CN120283054A (zh) 2022-12-09 2025-07-08 麒麟控股株式会社 具有聚对苯二甲酸乙二醇酯分解活性的蛋白质和分解聚对苯二甲酸乙二醇酯的方法
EP4653487A1 (en) 2023-02-03 2025-11-26 Spiber Inc. Polymer compound production method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595900A (en) 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1991012340A1 (en) 1990-02-14 1991-08-22 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
JP3756946B2 (ja) 1993-03-29 2006-03-22 協和醗酵工業株式会社 α１，３−フコシルトランスフェラーゼ

Also Published As

Publication number Publication date
EP0643132A1 (en) 1995-03-15
EP0643132A4 (en) 1999-01-13
DE69434749T2 (de) 2007-04-26
HK1012028A1 (en) 1999-07-23
SG49117A1 (en) 1998-05-18
EP0643132B1 (en) 2006-05-31
JP3756946B2 (ja) 2006-03-22
DE69434749D1 (de) 2006-07-06
US7094530B1 (en) 2006-08-22
US7709234B2 (en) 2010-05-04
US20060246468A1 (en) 2006-11-02
WO1994023021A1 (fr) 1994-10-13

Similar Documents

Publication Publication Date Title
BR1100704KB1 (pt) vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
BR9508053A (pt) Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga
BR9400656A (pt) Conjunto de controle para controlar um sistema, terminal de saída de imagem, e, processo para controlar um sistema
BR9205834A (pt) Sistema de radiotelefonia, e processo de verificação de um canal-alvo.
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
FI20050243L (fi) Stabiilia bakterisidista/läpäisevyyttä parantavaa proteiinifragmenttia koodittava DNA, vektori, isäntäsolu ja menetelmä näiden proteiinipigmenttien valmistamiseksi
EP0660234A3 (en) Remote code execution method and system.
EP0632286A3 (en) Self-adjusting method and device for determining direction based on self-structure.
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DE69819789D1 (de) Mit einem neuen plasmid transformierter e.coli stamm jm83/pkp2 und damit hergestellte phytase
BRPI9600729B8 (pt) vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada
KR960704045A (ko) E. coli csrA 유전자, 그것에 의해 암호화되는 단백질 및 그것의 사용법(THE ESCHERICHIA COLI carA GENE, PROTEIN ENCODED THEREBY, AND MITHODS OF USE THEREOF)
EP0759470A3 (en) Gene encoding endoglycoceramidase activator
BR9503132A (pt) Sistema de controle para queimador de combustivel gasoso método para controlar a operação de um queimador de gás combustivel,sistema de controle para controlar a operação de um queimador de combustivel gasoso,metodo para controlar a operação de quimador de combustivel gasoso método para controlar a operação de queimador de combustivel gasoso e método para controlar um queimador de combustivel gasoso
EP0751222A3 (en) Gene encoding endoglycoceramidase
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
BR9306150A (pt) Endo--1,4-glucanase sequéncia de dna recombinante vetor hospedeiro transformado contendo o vetor processo para a produç o de endo- -1,4-glucanase preparaç o de enzima e uso de endo- -1,4-glucanase
AU676277B2 (en) DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
NO995959L (no) DNA-sekvens, vektor, transformerte eukaryote eller prokaryote vertsceller, fremgangsmater for fremstilling av et protein, polypeptid, antistoff, fremgangsmate for isolering og identifisering, farmasoytisk sammensetning og fremgangsmate for screening.
ITGE930084A0 (it) Sicura,in particolare per fucili subaquei o simili.
IT7921839A0 (it) Sotto il controllo del promotore e vettori, derivati dal batteriofago dell'operatore dell'operon lattosio lambda, che permettono del batterio escherichia coli. l'inserimento e l'espressivita' di un gene, procariota o eucariota,
ITGE930005A0 (it) Forno a longheroni per il riscaldo accelerato di billette, o simili.
DK312787A (da) Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne